We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Says On-Sale Bar May Invalidate Angiomax Patent

Law360 (February 6, 2018, 10:52 PM EST) -- The Federal Circuit on Tuesday affirmed a district court’s finding that Hospira doesn’t infringe two blood thinner patents belonging to The Medicines Co., but remanded the question of whether The Medicines...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.